These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 3250683)

  • 21. Adjunctive yokukansan treatment improved cognitive functions in a patient with schizophrenia.
    Sakamoto S; Ujike H; Takaki M; Mizuki Y; Okahisa Y; Kodama M; Uchitomi Y
    J Neuropsychiatry Clin Neurosci; 2013; 25(3):E39-40. PubMed ID: 24026738
    [No Abstract]   [Full Text] [Related]  

  • 22. Subjective cognitive dysfunction in first-episode and chronic schizophrenic patients.
    Moritz S; Lambert M; Andresen B; Böthern A; Naber D; Krausz M
    Compr Psychiatry; 2001; 42(3):213-6. PubMed ID: 11349240
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cognitive deficits in schizophrenia.
    Marland G
    Nurs Times; 2000 Apr 20-26; 96(16):43-4. PubMed ID: 11309942
    [No Abstract]   [Full Text] [Related]  

  • 24. Age disorientation in Kraepelinian schizophrenia: frequency and clinical correlates.
    Tapp A; Tandon R; Scholten R; Dudley E
    Psychopathology; 1993; 26(3-4):225-8. PubMed ID: 8234639
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Absent inhibition of return and sustained facilitation in patients with schizophrenia in tertiary care.
    Wu C; Dagg P; Ward C; Crawford M
    Schizophr Res; 2011 Sep; 131(1-3):266-7. PubMed ID: 21419604
    [No Abstract]   [Full Text] [Related]  

  • 26. Attentional dysfunction of chronic schizophrenia: No association with long-term institutionalization.
    Cremasco L; Cappa SF
    Psychiatry Clin Neurosci; 2002 Aug; 56(4):419-23. PubMed ID: 12109960
    [TBL] [Abstract][Full Text] [Related]  

  • 27. M1 receptor agonism, a possible treatment for cognitive deficits in schizophrenia.
    Dean B
    Neuropsychopharmacology; 2004 Aug; 29(8):1583-4; author reply 1585-6. PubMed ID: 15266348
    [No Abstract]   [Full Text] [Related]  

  • 28. The problem of language and thought in schizophrenia: a review.
    Rieber RW; Vetter H
    J Psycholinguist Res; 1994 Mar; 23(2):149-95. PubMed ID: 8046671
    [No Abstract]   [Full Text] [Related]  

  • 29. Effect of intrinsic motivation on cognitive performance in schizophrenia: a pilot study.
    Fervaha G; Agid O; Foussias G; Remington G
    Schizophr Res; 2014 Jan; 152(1):317-8. PubMed ID: 24333003
    [No Abstract]   [Full Text] [Related]  

  • 30. [Cognitive impairment of chronic schizophrenics does not equate to dementia].
    Schenker T; Fischer RB
    Psychiatr Prax; 2000 Mar; 27(2):102. PubMed ID: 10738743
    [No Abstract]   [Full Text] [Related]  

  • 31. Need for culture specific tools to assess social cognition in schizophrenia.
    Mehta UM; Thirthalli J; Gangadhar BN; Keshavan MS
    Schizophr Res; 2011 Dec; 133(1-3):255-6. PubMed ID: 21962858
    [No Abstract]   [Full Text] [Related]  

  • 32. Social cognition in schizophrenia: recommendations from the measurement and treatment research to improve cognition in schizophrenia new approaches conference.
    Green MF; Olivier B; Crawley JN; Penn DL; Silverstein S
    Schizophr Bull; 2005 Oct; 31(4):882-7. PubMed ID: 16135561
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesizing schizophrenia: a bottom-up, symptomatic approach.
    Robbins TW
    Schizophr Bull; 2005 Oct; 31(4):854-64. PubMed ID: 16107585
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Determinants of work outcome in schizophrenia and schizoaffective disorder: role of cognitive function.
    Kaneda Y; Jayathilak K; Meltzer HY
    Psychiatry Res; 2009 Sep; 169(2):178-9. PubMed ID: 19646764
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of transcranial direct current stimulation on social cognition in schizophrenia: A preliminary study.
    Rassovsky Y; Dunn W; Wynn J; Wu AD; Iacoboni M; Hellemann G; Green MF
    Schizophr Res; 2015 Jul; 165(2-3):171-4. PubMed ID: 25934168
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Commentary on Martin & Pacherie. Out of nowhere: thought insertion, ownership and context-integration.
    Seeger M
    Conscious Cogn; 2013 Mar; 22(1):261-3. PubMed ID: 23376347
    [No Abstract]   [Full Text] [Related]  

  • 37. Doubtful association of antipsychotic polypharmacy and high dosage with cognition in chronic schizophrenia.
    Kontis D; Theochari E; Kleisas S; Kalogerakou S; Andreopoulou A; Psaras R; Makris Y; Karouzos C; Tsaltas E
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Oct; 34(7):1333-41. PubMed ID: 20691745
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical correlates of distinct topographies of tardive dyskinesia in schizophrenia.
    Waddington JL; Youssef HA; Kinsella A
    Am J Psychiatry; 1993 Nov; 150(11):1757-8. PubMed ID: 8105709
    [No Abstract]   [Full Text] [Related]  

  • 39. Aerobic exercise for cognitive deficits in schizophrenia - The impact of frequency, duration, and fidelity with target training intensity.
    Kimhy D; Lauriola V; Bartels MN; Armstrong HF; Vakhrusheva J; Ballon JS; Sloan RP
    Schizophr Res; 2016 Apr; 172(1-3):213-5. PubMed ID: 26852401
    [No Abstract]   [Full Text] [Related]  

  • 40. Measuring neuropsychological change in schizophrenia with novel antipsychotic medications.
    Purdon SE
    J Psychiatry Neurosci; 2000 Mar; 25(2):108-16. PubMed ID: 10740984
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.